Oniris, INRAE, LABERCA, Nantes, France.
TOXALIM (Research Centre in Food Toxicology), Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, 31027 Toulouse, France; Metatoul-AXIOM Platform, National Infrastructure for Metabolomics and Fluxomics: MetaboHUB, Toxalim, INRAE, F-31027 Toulouse, France.
Environ Int. 2020 Jun;139:105545. doi: 10.1016/j.envint.2020.105545. Epub 2020 Apr 29.
Large-scale suspect and non-targeted screening approaches based on high-resolution mass spectrometry (HRMS) are today available for chemical profiling and holistic characterisation of biological samples. These advanced techniques allow the simultaneous detection of a large number of chemical features, including markers of human chemical exposure. Such markers are of interest for biomonitoring, environmental health studies and support to risk assessment. Furthermore, these screening approaches have the promising capability to detect chemicals of emerging concern (CECs), document the extent of human chemical exposure, generate new research hypotheses and provide early warning support to policy. Whilst of growing importance in the environment and food safety areas, respectively, CECs remain poorly addressed in the field of human biomonitoring. This shortfall is due to several scientific and methodological reasons, including a global lack of harmonisation. In this context, the main aim of this paper is to present an overview of the basic principles, promises and challenges of suspect and non-targeted screening approaches applied to human samples as this specific field introduce major specificities compared to other fields. Focused on liquid chromatography coupled to HRMS-based data acquisition methods, this overview addresses all steps of these new analytical workflows. Beyond this general picture, the main activities carried out on this topic within the particular framework of the European Human Biomonitoring initiative (project HBM4EU, 2017-2021) are described, with an emphasis on harmonisation measures.
基于高分辨率质谱 (HRMS) 的大规模可疑物和非靶向筛选方法如今可用于化学分析和生物样本的整体特征描述。这些先进技术允许同时检测大量化学特征,包括人类化学暴露的标志物。这些标志物对于生物监测、环境健康研究和风险评估支持具有重要意义。此外,这些筛选方法具有检测新兴关注化学物质(CECs)的潜力,记录人类化学暴露的程度,生成新的研究假设,并为政策提供早期预警支持。尽管在环境和食品安全领域的重要性日益增加,但 CECs 在人体生物监测领域仍未得到充分解决。这种差距是由于几个科学和方法学原因造成的,包括全球缺乏协调。在这种情况下,本文的主要目的是概述可疑物和非靶向筛选方法应用于人体样本的基本原理、承诺和挑战,因为与其他领域相比,这一特定领域具有主要的特殊性。本文重点介绍了基于 HRMS 的液相色谱数据采集方法,概述了这些新分析工作流程的所有步骤。除了这个总体情况,还描述了在欧洲人体生物监测倡议(HBM4EU 项目,2017-2021 年)的特殊框架内就该主题开展的主要活动,重点是协调措施。